Oral manifestations in patients with familial adenomatous polyposis: A systematic review and meta-analysis

2016 ◽  
Vol 31 (3) ◽  
pp. 527-540 ◽  
Author(s):  
Fabiana Tolentino Almeida ◽  
Camila Pachêco-Pereira ◽  
André Luís Porporatti ◽  
Carlos Flores-Mir ◽  
André Ferreira Leite ◽  
...  
2022 ◽  
Author(s):  
Arthur S. Aelvoet ◽  
Daphne Struik ◽  
Barbara A. J. Bastiaansen ◽  
Willem A. Bemelman ◽  
Roel Hompes ◽  
...  

Abstract Desmoid tumours (DT) are one of the main causes of death in patients with familial adenomatous polyposis (FAP). Surgical trauma is a risk factor for DT, yet a colectomy is inevitable in FAP to prevent colorectal cancer. This systematic review and meta-analysis aimed to synthesize the available evidence on DT risk related to type, approach and timing of colectomy. A search was performed in MEDLINE, EMBASE and the Cochrane Library. Studies were considered eligible when DT incidence was reported after different types, approaches and timing of colectomy. Twenty studies including 6452 FAP patients were selected, all observational. No significant difference in DT incidence was observed after IRA versus IPAA (OR 0.99, 95% CI 0.69–1.42) and after open versus laparoscopic colectomy (OR 0.88, 95% CI 0.42–1.86). Conflicting DT incidences were seen after early versus late colectomy and when analysing open versus laparoscopic colectomy according to colectomy type. Three studies reported a (non-significantly) higher DT incidence after laparoscopic IPAA compared to laparoscopic IRA, with OR varying between 1.77 and 4.09. A significantly higher DT incidence was observed in patients with a history of abdominal surgery (OR 3.40, 95% CI 1.64–7.03, p = 0.001). Current literature does not allow to state firmly whether type, approach, or timing of colectomy affects DT risk in FAP patients. Fewer DT were observed after laparoscopic IRA compared to laparoscopic IPAA, suggesting laparoscopic IRA as the preferred choice if appropriate considering rectal polyp burden. PROSPERO registration number CRD42020161424.


2018 ◽  
Vol 18 (1) ◽  
pp. 53-62 ◽  
Author(s):  
Jirat Chenbhanich ◽  
Amporn Atsawarungruangkit ◽  
Sira Korpaisarn ◽  
Tanit Phupitakphol ◽  
Soravis Osataphan ◽  
...  

2010 ◽  
Vol 13 (11) ◽  
pp. 1222-1229 ◽  
Author(s):  
A. Sinha ◽  
P. P. Tekkis ◽  
D. C. Gibbons ◽  
R. K. Phillips ◽  
S. K. Clark

Author(s):  
Dina M. Elkady ◽  
Walid Shaban Abdella ◽  
Muhamed Abdella ◽  
Abdelrahman Elsayed Kopeya ◽  
Aboalmagd Hamdallah

Context: There is an unmet clinical need to develop simple, easy, rapid, and accessible testing for the detection of SARS-CoV-2. Recent reports suggested that saliva may be a host for the virus. The existence of SARS-CoV-2 in saliva can be associated with oral manifestations in infected patients. A systematic review was conducted as well as a meta-analysis to evaluate the diagnostic accuracy of detecting SARS-CoV-2 in saliva and investigate the association between positive saliva test and oral manifestations of COVID-19. Evidence acquisition: A literature search in MEDLINE via PubMed, Scopus, Web of Science, and Cochrane was done in June 2020 and updated in February 2021 using relevant keywords. We screened studies for eligibility. The extracted data were analyzed using Meta-Disc software. Results: Eighteen studies were included. Pooled data from eligible studies showed that the sensitivity of diagnosis of SARS-CoV-2 in saliva was 0.86 (95% CI, 0.83–0.89), and the specificity was 0.98 (95% CI, 0.96–0.98). COVID-19 was associated with oral diseases as amblygeustia, dry mouth, dryness, inflammation of the mouth, and enlargement of lymph nodes in the submandibular regions. Conclusions: Our results showed that the saliva has a high accuracy in the detection of SARS-CoV-2.


Sign in / Sign up

Export Citation Format

Share Document